Enhabit, Inc. (NYSE:EHAB – Get Free Report) has earned a consensus rating of “Hold” from the nine research firms that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, five have given a hold rating and three have given a buy rating to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $13.3143.
Several brokerages recently weighed in on EHAB. Leerink Partners upped their target price on shares of Enhabit from $9.50 to $13.80 and gave the stock a “market perform” rating in a report on Monday, February 23rd. Wolfe Research set a $12.00 price objective on Enhabit in a research note on Thursday, January 8th. Deutsche Bank Aktiengesellschaft upgraded Enhabit to a “buy” rating in a research report on Tuesday, January 13th. Jefferies Financial Group cut Enhabit from a “buy” rating to a “hold” rating and boosted their price target for the stock from $12.50 to $13.80 in a report on Monday, February 23rd. Finally, Truist Financial set a $13.80 price target on Enhabit in a research note on Monday, February 23rd.
Check Out Our Latest Stock Analysis on EHAB
Enhabit Price Performance
Institutional Trading of Enhabit
A number of institutional investors and hedge funds have recently bought and sold shares of EHAB. 8 Knots Management LLC boosted its holdings in shares of Enhabit by 20.5% during the 4th quarter. 8 Knots Management LLC now owns 5,084,714 shares of the company’s stock valued at $46,881,000 after purchasing an additional 865,868 shares during the last quarter. Vanguard Group Inc. boosted its stake in Enhabit by 8.2% during the third quarter. Vanguard Group Inc. now owns 3,393,069 shares of the company’s stock valued at $27,178,000 after buying an additional 256,559 shares during the last quarter. Geode Capital Management LLC grew its holdings in Enhabit by 1.0% during the 4th quarter. Geode Capital Management LLC now owns 1,187,434 shares of the company’s stock valued at $10,951,000 after buying an additional 11,583 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in Enhabit by 30.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 866,539 shares of the company’s stock worth $7,989,000 after acquiring an additional 201,269 shares during the last quarter. Finally, Hillsdale Investment Management Inc. purchased a new stake in shares of Enhabit during the 4th quarter worth approximately $7,567,000.
Enhabit Company Profile
Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.
The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.
Read More
- Five stocks we like better than Enhabit
- New Copper-Rich “Kraken” Zone Discovered
- Silver Is the New Oil—And the World’s Running Dry
- America’s 1776 happening again
- 3 Signs You May Want to Switch Financial Advisors
- Silver’s squeeze is tightening – opportunity forming
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.
